5UG-13075-85190
3 vaccinations
5 coded responses
15 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 337 / FL
- Registered
- 2022-09-02
- Relationship
- Child or adolescent in my care
- Guardian
- JYT-27518-89178
- Race
- N/A
- Ethnicity
- N/A
Timeline
-
2022-08-25
Dose 1 — Pfizer-BioNTechCo-administered: Polio:Rotavirus:Tetanus
-
2022-09-02
Registered in v-safe
-
2022-09-02
Health check-in — day 7, dose 1, under 3Feeling: Good · Sleepiness, Irritability/cryingUnder 3 check-in
- 2022-09-08
- 2022-09-22
-
2022-09-26
Dose 2 — Pfizer-BioNTechCo-administered: Flu
- 2022-09-29
-
2022-09-30
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Cough, Rhinorrhoea — Feeling: Good · Be unable to work or attend schoolFree text: Cough, runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-10-01
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Rhinorrhoea — Feeling: GoodFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-10-03
Survey response — day 7, dose 2, under 3MedDRA: Rhinorrhoea — Feeling: GoodFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-10-10
- 2022-10-19
- 2022-10-24
-
2022-11-07
Survey response — day 42, dose 2, under 3MedDRA: Respiratory tract infection — Feeling: Poor · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Respiratory infectionMedDRA releases: 2024-11 · check-in free text available
-
2022-11-07
Report sent to call center — day 42, dose 2, under 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-11-08
-
2022-11-29
Dose 3 — Pfizer-BioNTechCo-administered: Hepatitis B
-
2022-11-30
Health check-in — days 1–6 daily, dose 3, under 3Feeling: Poor · Site: Pain, Redness · Sleepiness, Loss of appetiteUnder 3 check-in
- 2022-12-02
- 2022-12-04
-
2023-02-28
Survey response — 3 months, dose 3, under 3MedDRA: COVID-19, Norovirus infection — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-02-28
Report sent to call center — 3 months, dose 3, under 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-03-01
- 2023-03-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-08-25 | Pfizer-BioNTech | Polio:Rotavirus:Tetanus |
| 2 | 2022-09-26 | Pfizer-BioNTech | Flu |
| 3 | 2022-11-29 | Pfizer-BioNTech | Hepatitis B |
Call center
2 call center cases
2 unsuccessful
Free text
Release 12 (Under 3) — days 1–6 daily, dose 2, under 3
Systemic reaction (other): Cough, runny nose
Systemic reaction (other): Runny nose
Release 12 (Under 3) — day 7, dose 2, under 3
Systemic reaction (other): Runny nose
Release 12 (Under 3) — day 42, dose 2, under 3
Symptoms: Respiratory infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Norovirus infection | · | · | ✓ |
| SD | Respiratory tract infection | · | · | ✓ |
| SRO | Cough | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release